Six Months After Publication of Key Studies, CombiMatrix Sees Growth in Prenatal Testing Adoption
IRVINE, Calif., June 18, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its volumes of prenatal ...http://www.nbcnews.com/id/52237928/ns/business-press_releases/t/six-months-after...


